Detection of masked hypertension in patients with metabolic-dysfunction associated steatotic liver disease using a novel clinical risk model
Related Experiment Video
Updated: Sep 16, 2025

07:03
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
1.1K
Philipp Kasper1, Münevver Demir2, Hans-Michael Steffen3,4,5
1Faculty of Medicine and University Hospital of Cologne, Department of Gastroenterology and Hepatology, University of Cologne, Cologne, Germany. Philipp.Kasper@uk-koeln.de.
Journal of Human Hypertension
|July 11, 2025
Abstract
No abstract available in PubMed .
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
52
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
52
Ultrasound II: Endoscopic Ultrasound and FibroScan
206
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
206

